Dermatologic disorders associated with thyroid disease

Joslyn Sciacca Kirby, William D. James

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Editorial Perspective: Thyroid diseases need to be considered as contributing to the clinical picture in patients with a host of systemic and dermatologic disorders, many of which are classified as autoimmune. Imagine the following scenario: A 46-year-old woman with a known history of systemic lupus erythematosus complains of the recent development of leg weakness. The clinician needs to determine if this could be due to the lupus itself, a reaction to treatment (such as a steroid-induced myopathy), or if there is a concurrent pathologic process. Considering thyroid disease in this context should be routine; however, it is all too often forgotten as a diagnostic possibility. It is also essential to consider if a patient's medications may be affecting thyroid function. For example, if a patient with cutaneous T-cell lymphoma (CTCL) develops xerosis to the point of being considered as having an acquired ichthyosis, is the ichthyotic skin secondary to the lymphoma or to bexarotene-induced central hypothyroidism? This chapter emphasizes those disorders and medications that merit screening for thyroid disease in the appropriate clinical context, utilizing thyroid function studies or thyroid autoantibodies. The ability to treat thyroid disease should provide an impetus for assessing the thyroid status in patients with the maladies discussed in this chapter. Assessing thyroid function should be considered standard practice in patients with a personal or family history of any autoimmune disease.

Original languageEnglish (US)
Title of host publicationThyroid Disorders with Cutaneous Manifestations
PublisherSpringer Berlin Heidelberg
Pages157-179
Number of pages23
ISBN (Print)9781848001862
DOIs
StatePublished - Dec 1 2008

Fingerprint

Thyroid Diseases
Thyroid Gland
Cutaneous T-Cell Lymphoma
Aptitude
Muscular Diseases
Pathologic Processes
Hypothyroidism
Systemic Lupus Erythematosus
Autoantibodies
Autoimmune Diseases
Lymphoma
Leg
Steroids
Skin

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Sciacca Kirby, J., & James, W. D. (2008). Dermatologic disorders associated with thyroid disease. In Thyroid Disorders with Cutaneous Manifestations (pp. 157-179). Springer Berlin Heidelberg. https://doi.org/10.1007/978-1-84800-187-9_13
Sciacca Kirby, Joslyn ; James, William D. / Dermatologic disorders associated with thyroid disease. Thyroid Disorders with Cutaneous Manifestations. Springer Berlin Heidelberg, 2008. pp. 157-179
@inbook{cdeecdaa600d4ee7813976821e280a9b,
title = "Dermatologic disorders associated with thyroid disease",
abstract = "Editorial Perspective: Thyroid diseases need to be considered as contributing to the clinical picture in patients with a host of systemic and dermatologic disorders, many of which are classified as autoimmune. Imagine the following scenario: A 46-year-old woman with a known history of systemic lupus erythematosus complains of the recent development of leg weakness. The clinician needs to determine if this could be due to the lupus itself, a reaction to treatment (such as a steroid-induced myopathy), or if there is a concurrent pathologic process. Considering thyroid disease in this context should be routine; however, it is all too often forgotten as a diagnostic possibility. It is also essential to consider if a patient's medications may be affecting thyroid function. For example, if a patient with cutaneous T-cell lymphoma (CTCL) develops xerosis to the point of being considered as having an acquired ichthyosis, is the ichthyotic skin secondary to the lymphoma or to bexarotene-induced central hypothyroidism? This chapter emphasizes those disorders and medications that merit screening for thyroid disease in the appropriate clinical context, utilizing thyroid function studies or thyroid autoantibodies. The ability to treat thyroid disease should provide an impetus for assessing the thyroid status in patients with the maladies discussed in this chapter. Assessing thyroid function should be considered standard practice in patients with a personal or family history of any autoimmune disease.",
author = "{Sciacca Kirby}, Joslyn and James, {William D.}",
year = "2008",
month = "12",
day = "1",
doi = "10.1007/978-1-84800-187-9_13",
language = "English (US)",
isbn = "9781848001862",
pages = "157--179",
booktitle = "Thyroid Disorders with Cutaneous Manifestations",
publisher = "Springer Berlin Heidelberg",

}

Sciacca Kirby, J & James, WD 2008, Dermatologic disorders associated with thyroid disease. in Thyroid Disorders with Cutaneous Manifestations. Springer Berlin Heidelberg, pp. 157-179. https://doi.org/10.1007/978-1-84800-187-9_13

Dermatologic disorders associated with thyroid disease. / Sciacca Kirby, Joslyn; James, William D.

Thyroid Disorders with Cutaneous Manifestations. Springer Berlin Heidelberg, 2008. p. 157-179.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Dermatologic disorders associated with thyroid disease

AU - Sciacca Kirby, Joslyn

AU - James, William D.

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Editorial Perspective: Thyroid diseases need to be considered as contributing to the clinical picture in patients with a host of systemic and dermatologic disorders, many of which are classified as autoimmune. Imagine the following scenario: A 46-year-old woman with a known history of systemic lupus erythematosus complains of the recent development of leg weakness. The clinician needs to determine if this could be due to the lupus itself, a reaction to treatment (such as a steroid-induced myopathy), or if there is a concurrent pathologic process. Considering thyroid disease in this context should be routine; however, it is all too often forgotten as a diagnostic possibility. It is also essential to consider if a patient's medications may be affecting thyroid function. For example, if a patient with cutaneous T-cell lymphoma (CTCL) develops xerosis to the point of being considered as having an acquired ichthyosis, is the ichthyotic skin secondary to the lymphoma or to bexarotene-induced central hypothyroidism? This chapter emphasizes those disorders and medications that merit screening for thyroid disease in the appropriate clinical context, utilizing thyroid function studies or thyroid autoantibodies. The ability to treat thyroid disease should provide an impetus for assessing the thyroid status in patients with the maladies discussed in this chapter. Assessing thyroid function should be considered standard practice in patients with a personal or family history of any autoimmune disease.

AB - Editorial Perspective: Thyroid diseases need to be considered as contributing to the clinical picture in patients with a host of systemic and dermatologic disorders, many of which are classified as autoimmune. Imagine the following scenario: A 46-year-old woman with a known history of systemic lupus erythematosus complains of the recent development of leg weakness. The clinician needs to determine if this could be due to the lupus itself, a reaction to treatment (such as a steroid-induced myopathy), or if there is a concurrent pathologic process. Considering thyroid disease in this context should be routine; however, it is all too often forgotten as a diagnostic possibility. It is also essential to consider if a patient's medications may be affecting thyroid function. For example, if a patient with cutaneous T-cell lymphoma (CTCL) develops xerosis to the point of being considered as having an acquired ichthyosis, is the ichthyotic skin secondary to the lymphoma or to bexarotene-induced central hypothyroidism? This chapter emphasizes those disorders and medications that merit screening for thyroid disease in the appropriate clinical context, utilizing thyroid function studies or thyroid autoantibodies. The ability to treat thyroid disease should provide an impetus for assessing the thyroid status in patients with the maladies discussed in this chapter. Assessing thyroid function should be considered standard practice in patients with a personal or family history of any autoimmune disease.

UR - http://www.scopus.com/inward/record.url?scp=84892245283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892245283&partnerID=8YFLogxK

U2 - 10.1007/978-1-84800-187-9_13

DO - 10.1007/978-1-84800-187-9_13

M3 - Chapter

AN - SCOPUS:84892245283

SN - 9781848001862

SP - 157

EP - 179

BT - Thyroid Disorders with Cutaneous Manifestations

PB - Springer Berlin Heidelberg

ER -

Sciacca Kirby J, James WD. Dermatologic disorders associated with thyroid disease. In Thyroid Disorders with Cutaneous Manifestations. Springer Berlin Heidelberg. 2008. p. 157-179 https://doi.org/10.1007/978-1-84800-187-9_13